Jesse L. Bobbitt

714 total citations
17 papers, 621 citations indexed

About

Jesse L. Bobbitt is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jesse L. Bobbitt has authored 17 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Jesse L. Bobbitt's work include Enzyme Production and Characterization (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Bone health and treatments (2 papers). Jesse L. Bobbitt is often cited by papers focused on Enzyme Production and Characterization (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Bone health and treatments (2 papers). Jesse L. Bobbitt collaborates with scholars based in United States. Jesse L. Bobbitt's co-authors include John Sharp, Edward D. Mihelich, R. N. Hull, P. J. Burck, David W. Snyder, Peter P.K. Ho, Bruce H. Frank, LaVerne D. Boeck, Cynthia D. Sommers and Stephen M. Krane and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jesse L. Bobbitt

17 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesse L. Bobbitt United States	11	379	116	95	70	68	17	621
Jean Bowen United States	3	348 0.9×	39 0.3×	125 1.3×	74 1.1×	44 0.6×	4	625
John D. Benson United States	16	520 1.4×	82 0.7×	100 1.1×	93 1.3×	64 0.9×	22	946
R. G. Ebb United States	7	743 2.0×	68 0.6×	90 0.9×	84 1.2×	173 2.5×	7	933
Barbara Lamb United States	18	418 1.1×	129 1.1×	90 0.9×	51 0.7×	75 1.1×	27	633
Ivan T. Oliver Australia	15	476 1.3×	83 0.7×	71 0.7×	82 1.2×	361 5.3×	20	1.0k
Karen W. Barbour United States	16	426 1.1×	61 0.5×	86 0.9×	73 1.0×	66 1.0×	30	721
Werner Bollag Switzerland	14	918 2.4×	263 2.3×	114 1.2×	104 1.5×	211 3.1×	25	1.2k
Chandra P. Leo United States	10	440 1.2×	69 0.6×	87 0.9×	40 0.6×	85 1.3×	15	615
L. J. Journey United States	12	307 0.8×	48 0.4×	41 0.4×	103 1.5×	41 0.6×	13	558
Josephine A. Carew United States	16	626 1.7×	65 0.6×	125 1.3×	75 1.1×	245 3.6×	32	1.1k

Countries citing papers authored by Jesse L. Bobbitt

Since Specialization

Citations

This map shows the geographic impact of Jesse L. Bobbitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse L. Bobbitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse L. Bobbitt more than expected).

Fields of papers citing papers by Jesse L. Bobbitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse L. Bobbitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse L. Bobbitt. The network helps show where Jesse L. Bobbitt may publish in the future.

Co-authorship network of co-authors of Jesse L. Bobbitt

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse L. Bobbitt. A scholar is included among the top collaborators of Jesse L. Bobbitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse L. Bobbitt. Jesse L. Bobbitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Fox, Niles, Min Song, James Schrementi, et al.. (1996). Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. European Journal of Pharmacology. 308(2). 195–203. 32 indexed citations

Fleisch, J H, Edward D. Mihelich, Stephen M. Spaethe, et al.. (1996). Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 252–257. 19 indexed citations

Snyder, David W., Cynthia D. Sommers, Jesse L. Bobbitt, & Edward D. Mihelich. (1993). Characterization of the contractile effects of human recombinant nonpancreatic secretory phospholipase A2 (PLA2) and other PLA2s on guinea pig lung pleural strips.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1147–1155. 10 indexed citations

Snyder, David W., Cynthia D. Sommers, Jesse L. Bobbitt, & Edward D. Mihelich. (1992). Evidence that phospholipase A2 (PLA2) inhibitors can selectively block PLA2-mediated contractions of guinea pig lung pleural strips.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 1147–1153. 4 indexed citations

Sommers, Cynthia D., Jesse L. Bobbitt, Kerry G. Bemis, & David W. Snyder. (1992). Porcine pancreatic phospholipase A2-induced contractions of guinea pig lung pleural strips. European Journal of Pharmacology. 216(1). 87–96. 36 indexed citations

Wery, Jean‐Pierre, Richard W. Schevitz, David K. Clawson, et al.. (1991). Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution. Nature. 352(6330). 79–82. 182 indexed citations

Jackson, Charles V., Trelia J. Craft, Brian W. Grinnell, et al.. (1990). Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis.. Circulation. 82(3). 930–940. 23 indexed citations

Butler, Larry, et al.. (1989). Interleukin 1-induced pathophysiology: Induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clinical Immunology and Immunopathology. 53(3). 400–421. 53 indexed citations

Scheetz, Maurice E., et al.. (1986). Characterization and specificity of a high titre polyclonal goat anti-murine IL-1 antibody.. PubMed. 59(4). 535–9. 9 indexed citations

10.

Dayer, J M, J D Vassalli, Jesse L. Bobbitt, et al.. (1981). Calcitonin stimulates plasminogen activator in porcine renal tubular cells: LLC-PK1.. The Journal of Cell Biology. 91(1). 195–200. 76 indexed citations

11.

Bobbitt, Jesse L., et al.. (1980). Effect of Carnitine Analogs on Carnitine Acetyltransferase. Journal of Pharmaceutical Sciences. 69(2). 202–204. 6 indexed citations

12.

Bobbitt, Jesse L., et al.. (1980). Studies on plasminogen activator from pig kidney cell cultures. III. Purification and characterization. Thrombosis Research. 18(3-4). 315–332. 7 indexed citations

13.

Bobbitt, Jesse L., et al.. (1979). Immunocytochemical localization of plasminogen activator on porcine kidney cell strain: LLC-PK1 (LP100).. Journal of Histochemistry & Cytochemistry. 27(6). 1035–1040. 10 indexed citations

14.

Bobbitt, Jesse L., et al.. (1977). Use of peptidyl-4-methoxy-2-naphthylamides to assay plasmin. Analytical Biochemistry. 80(2). 355–365. 28 indexed citations

15.

Yen, Terence T., et al.. (1972). Identification and Characterization of Pituitary Triose‐Phosphate Isomerase. European Journal of Biochemistry. 24(3). 416–420. 2 indexed citations

16.

Ho, Peter P.K., et al.. (1970). Crystalline l-Asparaginase from Escherichia coli B. Journal of Biological Chemistry. 245(14). 3708–3715. 111 indexed citations

17.

Bobbitt, Jesse L. & Robert S. Levy. (1965). Proteins of S_f 10-400 Lipoproteins from Lipemic Human Plasma^*. Biochemistry. 4(7). 1282–1288. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact